{"id":50606,"date":"2022-11-08T14:02:43","date_gmt":"2022-11-08T13:02:43","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/"},"modified":"2022-11-08T14:02:43","modified_gmt":"2022-11-08T13:02:43","slug":"scholar-rock-to-participate-in-upcoming-investor-conferences","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/","title":{"rendered":"Scholar Rock to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div>\n<p>CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/5\/Scholar_Rock_Logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nGuggenheim 4<sup>th<\/sup> Annual Neuro\/Immunology Conference on Tuesday, November 15, 2022, from 2:10-2:35 p.m. ET.\n<\/li>\n<li>\nPiper Sandler 34<sup>th<\/sup> Annual Healthcare Conference on Tuesday, November 29, 2022, from 8:00-8:25 a.m. ET.\n<\/li>\n<\/ul>\n<p>\nLive webcast of both events may be accessed by visiting the Investors &amp; Media section of the Scholar Rock website at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Finvestors.scholarrock.com&amp;esheet=52961759&amp;newsitemid=20221108005051&amp;lan=en-US&amp;anchor=http%3A%2F%2Finvestors.scholarrock.com&amp;index=1&amp;md5=1277c18827060964c78e4a5175658091\" rel=\"nofollow noopener\" shape=\"rect\">http:\/\/investors.scholarrock.com<\/a>. An archived replay of the webcast will be available on the Company\u2019s website for approximately 90 days following the presentations.\n<\/p>\n<p>\n<b>About Scholar Rock<\/b>\n<\/p>\n<p>\nScholar Rock is a clinical-stage biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Scholar Rock is creating a pipeline of novel product candidates with the potential to transform the lives of patients suffering from a wide range of serious diseases, including neuromuscular disorders, cancer, and fibrosis. Scholar Rock\u2019s approach to targeting the molecular mechanisms of growth factor activation enabled it to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. By developing product candidates that act in the disease microenvironment, the Company intends to avoid the historical challenges associated with inhibiting growth factors for therapeutic effect. Scholar Rock believes its focus on biologically validated growth factors may facilitate a more efficient development path. For more information, please visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.ScholarRock.com&amp;esheet=52961759&amp;newsitemid=20221108005051&amp;lan=en-US&amp;anchor=www.ScholarRock.com&amp;index=2&amp;md5=672ce5a3c37599e098d79db5de3d2625\" rel=\"nofollow noopener\" shape=\"rect\">www.ScholarRock.com<\/a> or follow Scholar Rock on Twitter (@ScholarRock) and LinkedIn (<a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fscholar-rock%2F&amp;esheet=52961759&amp;newsitemid=20221108005051&amp;lan=en-US&amp;anchor=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fscholar-rock%2F&amp;index=3&amp;md5=27401dcef1fea0102cefa7770f000d90\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.linkedin.com\/company\/scholar-rock\/<\/a>).\n<\/p>\n<p>\n<b>Availability of Other Information About Scholar Rock<\/b>\n<\/p>\n<p>\nInvestors and others should note that we communicate with our investors and the public using our company website <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.scholarrock.com&amp;esheet=52961759&amp;newsitemid=20221108005051&amp;lan=en-US&amp;anchor=www.scholarrock.com&amp;index=4&amp;md5=74e8ac993d6392c8c3101902051b0fb4\" rel=\"nofollow noopener\" shape=\"rect\">www.scholarrock.com<\/a>, including, but not limited to, company disclosures, investor presentations and FAQs, Securities and Exchange Commission filings, press releases, public conference call transcripts, and webcast transcripts, as well as on Twitter and LinkedIn. The information that we post on our website or on Twitter or LinkedIn could be deemed to be material information. As a result, we encourage investors, the media and others interested to review the information that we post there on a regular basis. The contents of our website or social media shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended.\n<\/p>\n<p>\nScholar Rock\u00ae is a registered trademark of Scholar Rock, Inc.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Scholar Rock:<\/b><br \/><b>Investors<\/b><br \/>Rushmie Nofsinger<br \/>\n<br \/>Scholar Rock<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;&#x69;&#x6c;t&#x6f;&#58;m&#x72;&#110;o&#x66;&#115;&#x69;&#x6e;g&#x65;&#114;&#64;&#x73;&#99;h&#x6f;&#108;&#x61;&#x72;&#114;&#x6f;&#x63;k&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">rno&#102;&#115;&#105;&#x6e;&#x67;&#x65;&#x72;&#x40;&#x73;cho&#108;&#97;&#114;&#114;&#x6f;&#x63;&#x6b;&#x2e;&#x63;&#x6f;m<\/a><br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#116;o&#x3a;&#105;r&#x40;&#115;c&#x68;&#111;l&#x61;&#114;r&#x6f;&#99;k&#x2e;&#99;o&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#114;&#x40;&#x73;c&#x68;&#111;l&#x61;&#114;r&#x6f;&#99;&#x6b;&#x2e;c&#x6f;&#109;<\/a><br \/>857-259-5573<\/p>\n<p><b>Media<\/b><br \/>Ariane Lovell<br \/>\n<br \/>Finn Partners<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;a&#x69;&#108;t&#x6f;&#58;&#x61;&#114;i&#x61;&#110;&#x65;&#46;l&#x6f;&#118;&#x65;&#x6c;l&#x40;&#102;i&#x6e;&#110;&#x70;&#97;r&#x74;&#110;&#x65;&#114;s&#x2e;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x61;&#x72;&#x69;&#97;&#110;e&#46;&#x6c;&#x6f;&#x76;&#x65;&#108;&#108;&#64;f&#x69;&#x6e;&#x6e;&#112;&#97;&#114;tn&#x65;&#x72;&#x73;&#46;&#99;om<\/a><br \/><a target=\"_blank\" href=\"m&#97;&#x69;&#x6c;t&#111;&#58;&#x6d;&#x65;d&#105;&#97;&#x40;&#x73;c&#104;&#x6f;&#x6c;&#x61;r&#114;&#x6f;&#x63;k&#46;&#99;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">m&#101;&#x64;&#x69;a&#64;&#x73;&#x63;h&#111;&#108;&#x61;&#x72;r&#111;&#x63;&#x6b;&#46;&#99;&#x6f;&#x6d;<\/a><br \/>917-565-2204\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences: Guggenheim 4th Annual Neuro\/Immunology Conference on Tuesday, November 15, 2022, from 2:10-2:35 p.m. ET. Piper &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50606","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences: Guggenheim 4th Annual Neuro\/Immunology Conference on Tuesday, November 15, 2022, from 2:10-2:35 p.m. ET. Piper ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T13:02:43+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Scholar Rock to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2022-11-08T13:02:43+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/\"},\"wordCount\":466,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005051\\\/en\\\/1626664\\\/21\\\/Scholar_Rock_Logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/\",\"name\":\"Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005051\\\/en\\\/1626664\\\/21\\\/Scholar_Rock_Logo.jpg\",\"datePublished\":\"2022-11-08T13:02:43+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005051\\\/en\\\/1626664\\\/21\\\/Scholar_Rock_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221108005051\\\/en\\\/1626664\\\/21\\\/Scholar_Rock_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/scholar-rock-to-participate-in-upcoming-investor-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Scholar Rock to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend","og_description":"CAMBRIDGE, Mass.&#8211;(BUSINESS WIRE)&#8211;Scholar Rock (NASDAQ: SRRK), a Phase 3 clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth factors play a fundamental role, today announced that management will participate in the following upcoming investor conferences: Guggenheim 4th Annual Neuro\/Immunology Conference on Tuesday, November 15, 2022, from 2:10-2:35 p.m. ET. Piper ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-08T13:02:43+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Scholar Rock to Participate in Upcoming Investor Conferences","datePublished":"2022-11-08T13:02:43+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/"},"wordCount":466,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/","url":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/","name":"Scholar Rock to Participate in Upcoming Investor Conferences - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg","datePublished":"2022-11-08T13:02:43+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221108005051\/en\/1626664\/21\/Scholar_Rock_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/scholar-rock-to-participate-in-upcoming-investor-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Scholar Rock to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50606","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50606"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50606\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50606"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50606"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50606"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}